Navigation Links
A Statement from GlaxoSmithKline Consumer Healthcare on FDA Regulation of Smokeless Tobacco Products
Date:9/27/2010

PARSIPPANY, N.J., Sept. 27 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare, a leader in helping smokers quit and the marketer of nicotine replacement therapy (NRT) products, including Nicorette® and NicoDerm® CQ®, supports the findings of the American Heart Association (AHA) policy statement regarding smokeless tobacco products.(1) GSK Consumer Healthcare agrees that these products should not be used as an alternative to cigarettes or for smoking cessation due to the potential negative health consequences and their impact on smoking behavior. 

The AHA statement is important because the U.S. Food and Drug Administration (FDA) has just finished accepting comments from the public on how FDA should regulate certain smokeless tobacco products.  GSK Consumer Healthcare submitted a comment to the FDA on the potential public health impact of oral dissolvable tobacco products.  In our submission, GSK Consumer Healthcare called for oral dissolvable tobacco products to be withdrawn from the market until their sponsors can demonstrate to FDA that their marketing is appropriate for the protection of public health.

The AHA policy statement, notes that smokeless tobacco products are not safe alternatives to smoking and are associated with heart attack, stroke and certain cancers.(1)  Also, due to the marketing of these products, smokeless tobacco products may also initiate further tobacco use and perpetuate smoking.(1) 

Tobacco use, including smokeless tobacco, is the largest cause of preventable death and disease in the world.(2)  More than 400,000 Americans die every year from tobacco-related disease.(2)  The only proven way to reduce these health consequences is to stop using tobacco complete
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine
2. Statement from CHPA on Todays FDA Advisory Committee Meeting on Dextromethorphan
3. Media Statement: Robert Moussa, President and CEO, Dilon Diagnostics
4. Statement from Eli Lilly and Company Regarding Approval Recommendation from FDA Advisory Committee for Expanding the Pain Indications for Cymbalta® to a Broader Pain Population
5. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
6. NCPA Statement on CVS Caremark-Aetna Agreement
7. GlaxoSmithKline Statement in Response to FDA Advisory Committees Vote on Safety of Avandia® (rosiglitazone)
8. Dendreon Statement on CMS National Coverage Analysis
9. NORD Calls for Statement of Policy on Orphan Drug Development
10. Teva Admits to Making False Statements in US Gianvi™ Label and Agrees to Corrective Measures
11. Alexza Pharmaceuticals Files Shelf Registration Statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... -- LCA-Vision Inc. (NASDAQ: LCAV ), a leading provider ... brand, announces that all nominees to the company,s Board of ... of stockholders.  These Directors are: , William ... Gaynor Investment Counsel , John C. Hassan ... Edgar F. Heizer III , Chairman of Manus Health ...
(Date:5/21/2013)... 2013 /PRNewswire-iReach/ -- The 2013 Pharma ChemOutsourcing Show slated ... greatest number of "Emerging" small molecule biotech company ... Alexay .  "No one saw this coming", ... show,s still 4 months away and we may end ... big surprise and great news for attendees". Thecurrent list ...
(Date:5/21/2013)... PARK, N.J. , May 21, 2013 /PRNewswire/ ... the launch of the new Armada corporate website ... to clearly communicate Armada,s unique and first-to-market services ... service company focused on the specialty pharmacy industry. ... continued expansion of the Armada business model in ...
Breaking Medicine Technology:LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2
... enjoyed widespread use of its flocked swabs line, branded ... of bacterial and viral samples. FLOQSwabs ... to collect more sample and elute the entire sample ... agents. In spite of this success, the company has ...
... Dec. 16, 2010 Astrum Hearing Inc., an organization of ... way affiliated with Astrum Marketing Inc., also known as Astrum ... bankruptcy pending in the Middle District of Florida. In addition, ... "Sears Hearing By Astrum" centers. Astrum Hearing Inc. ...
Cached Medicine Technology:COPAN Files New Patents Following the Development of High Nucleic Acid Yield Flocked Swabs 2Astrum Hearing Inc. Is Not Affiliated with Astrum Hearing Aid Centers or Astrum Marketing 2
(Date:5/21/2013)... (PRWEB) May 21, 2013 Today, Zane ... HSA and FSA accounts. Zane Benefits, which provides ... benefits, is the leader in defined contribution ... arrangements . , According to Zane Benefits’ website, the ... was signed into law in 2010 and impacts many ...
(Date:5/21/2013)... May 21, 2013 Two executives from ... (SBG) will identify which strategies can be most effective ... care to the members who are taking them, in ... Inc., “How to Manage Specialty Drugs to Reduce ... are now the main driver for rising prescription drug ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 While North ... synonymous with comprehensive travel guides. Brunswick Plantation & Golf ... packages that include access to 27 holes of "Top10" ... courses in North Carolina, knowing the Top 10 ... Lodges takes away the overwhelming task of selecting the ...
(Date:5/21/2013)... 21, 2013 Octo Consulting Group, ... management consulting solutions to the Federal marketplace, has ... In the newly created role, Denny will ... of the firm’s business development function to include ... functions, and leading strategies to achieve the firm’s ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... for patients having severe bouts of chronic obstructive pulmonary ... of glucocorticoid treatment with prednisone to treat COPD flare-ups ... with fewer chances for adverse side effects, they said. ... of treatment was not less effective than 14 days," ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3
... following is a statement from Matthew L. Myers, ... Mayor Sheila Dixon and Baltimore City Health Commissioner ... city,s children and health by issuing final regulations ... cigars. Under the regulation, cheap cigars would have ...
... Support for SCHIP ReauthorizationWASHINGTON, Jan. 14 The following ... the Speaker of the House: Divided We Fail Partnership ... SEIU) , "On behalf of Divided We Fail, ... strengthen the State Children,s Health Insurance Program (SCHIP). Our ...
... highlights:-- Cholesterol-lowering drug adherence drops with an increase ... for 90 straight days without medication was three ... group and twice as high in patients in ... exempt group (received prescriptions without a co-payment).-- Researchers ...
... Delivery SystemCARLSBAD, Calif., Jan. 14 SkinMedica, Inc. ... Wash, the only prescription benzoyl peroxide wash ... system, for the treatment of mild to moderate ... 7% benzoyl peroxide.(Photo: http://www.newscom.com/cgi-bin/prnh/20090114/LA58962 )NeoBenz ...
... Experience with Complex Rehab MarketHOUSTON, Jan. 14 Anne ... of experience, has joined Alliance Seating & Mobility ... complex rehab companies. Kieschnik is an Assistive Technology ... in Houston, Texas, for ASM ( www.alliance-seating.com ) and ...
... Association rapid access journal reportStudy highlights:, , ... determine the odds of having cardiovascular disease within 10 years may ... Most adults 50 years and younger have a low ... for heart disease. , Researchers ...
Cached Medicine News:Health News:Baltimore's Ban on Sale of Single, Cheap Cigars Will Protect Kids and Health 2Health News:Health Care For 11 Million Children 2Health News:Health Care For 11 Million Children 3Health News:Health Care For 11 Million Children 4Health News:Co-Payment Increases Result in Gaps in Veterans' Prescription Usage 2Health News:Co-Payment Increases Result in Gaps in Veterans' Prescription Usage 3Health News:Co-Payment Increases Result in Gaps in Veterans' Prescription Usage 4Health News:SkinMedica(R) Launches NeoBenz(R) Micro Wash for Acne 2Health News:SkinMedica(R) Launches NeoBenz(R) Micro Wash for Acne 3Health News:Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas 2Health News:Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas 3Health News:Half of Adults 50 and Younger With Low 10-Year Risk of CVD Have High Lifetime Risk 2Health News:Half of Adults 50 and Younger With Low 10-Year Risk of CVD Have High Lifetime Risk 3
... provide protection to the exposed airway of the ... making it ideal for active young children as ... heat and moisture recovery, it ensures patient comfort ... filters have ISO standard tapered ends to assure ...
... protection to the exposed airway of the tracheostomy ... it ideal for active young children as well ... and moisture recovery, it ensures patient comfort and ... have ISO standard tapered ends to assure a ...
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines ...
Indications For Usage: , ,For use during pulmonary lung function testing...
Medicine Products: